Elvitegravir and Trospium / Xanomeline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Trospium / Xanomeline
Elvitegravir
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed Cobenfy (which contains xanomeline) along with elvitegravir, an HIV medicine. Here's what's going on: the xanomeline part of Cobenfy can briefly slow down an enzyme in your gut called CYP3A4. That enzyme helps break down elvitegravir. When it's slowed, a little more elvitegravir may get into your body than usual.
In plain terms, that could mean a slightly higher chance of elvitegravir side effects. I want to be honest, though: this concern is theoretical, meaning it's based on how the drugs work rather than clear real-world reports. Your care team can manage this easily by keeping an eye on how you feel, so keep taking both as prescribed and mention any new symptoms.
Mechanism: Xanomeline (in Cobenfy) transiently inhibits intestinal CYP3A4 without meaningful systemic inhibition. Elvitegravir is a CYP3A4 substrate, so co-administration may increase its oral exposure (AUC/Cmax) and the frequency/severity of substrate-related adverse effects.
Direction: Increased elvitegravir exposure (neither agent acts as a prodrug here).
- Onset: unspecified
- Evidence: theoretical
- Severity: moderate
- Management: No fixed dose change is defined; monitor for increased or more frequent elvitegravir-related adverse reactions. Dosing may be individualized by the care team if warranted.
What happens
Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-related adverse reactions
Interaction Deep Dive
In the gut, xanomeline produces a temporary, localized inhibition of CYP3A4, though this effect does not extend systemically. When xanomeline is taken alongside oral medications that are sensitive substrates of CYP3A4, the exposure to those oral sensitive CYP3A4 substrates may rise. As a result, adverse reactions attributable to these substrates could occur more often and/or with greater severity. For patients receiving both agents together, watch for any increase in the frequency and/or severity of adverse reactions associated with oral drugs that are sensitive substrates of CYP3A41.
Why it happens (mechanism)
Inhibition of CYP3A4-substrate metabolism by xanomeline
How to manage this interaction
Good news: this is usually manageable, and both medicines can typically continue as prescribed.
- Keep taking both exactly as directed unless your prescriber tells you otherwise.
- Watch for side effects from elvitegravir, such as nausea, headache, or feeling unusually off, and report anything new.
- Your care team may monitor you more closely, and your dose may be adjusted and individualized if needed.
- Ask your pharmacist or doctor before starting or stopping any medicine while on this combination.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Elvitegravir and Trospium / Xanomeline together?
Cobenfy (xanomeline) may modestly raise elvitegravir levels by briefly slowing gut CYP3A4, so watch for more elvitegravir side effects; this is theoretical and your care team can manage it by monitoring you and tailoring the dose if needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Elvitegravir and Trospium / Xanomeline interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Elvitegravir and Trospium / Xanomeline interaction managed?
Good news: this is usually manageable, and both medicines can typically continue as prescribed. Keep taking both exactly as directed unless your prescriber tells you otherwise. Watch for side effects from elvitegravir, such as nausea, headache, or feeling unusually off, and report anything new. Your care team may monitor you more closely, and your dose may be adjusted and individualized if needed.… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Elvitegravir or Trospium / Xanomeline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Citation #1
Keep reading about Trospium / Xanomeline
Keep reading about Elvitegravir
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist